Business Daily from THE HINDU group of publications
Friday, Apr 18, 2008
ePaper | Mobile/PDA Version | Audio


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Mergers & Acquisitions
Siro Clinpharm buys German clinical research firm

Our Bureau

Mumbai, April 17 Clinical research organisation Siro Clinpharm Pvt Ltd has acquired 100 per cent equity in Germany-based Omega Mediation Group in an all-cash deal, but for an undisclosed sum.

The acquisition marks Siro Clinpharm’s entry into Europe, said Dr Chetan Tamhankar, Chief Operating Officer, Siro Clinpharm. Omega has around 120 people, across its operations in Greece, Estonia and Israel. And there will be no change in the management or employee structure as the operations expand, he said.

The company’s combined turnover, including the recently acquired Omega, is about Rs 200 crore, Dr Tamhankar said, and the clinical research organisation (CRO) targets Rs 400 crore by 2010. The company expects to double its business by expanding operations into South-East Asia and South America, he said, indicating that acquisitions were part of the plan.

Fund raising

Funds for the Omega acquisition were raised through internal funding and debt, he said. Promoted by the Daftary family, last year, the CRO saw two private equity firms (Kotak and 3i) invest in the company, he said, without giving details.

In another two years, the CRO expects to achieve a critical mass that would allow it to go in for a listing, he added.

At present, there are about 300 Siro-managed or conducted clinical trials being done in India, he said.

Its operations include clinical studies, data management, bio-statistics and medical writing.

Manpower

The Mumbai-based Siro Clinpharma has at present 400 people between its operation in India and the US. In July last year, Siro Clinpharm had acquired Global Client Partners, a US-based CRO with client networks in the US biotech and pharma companies.

The US acquisition gave Siro a front-end operation, he said, and added that the latest European acquisition would add to the geographical spread of the services that Siro can offer clients.

More Stories on : Mergers & Acquisitions | Pharmaceuticals | Research & Development

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
SAIL to hold prices


Electrotherm to raise funds
‘Cos willing to settle currency derivative cases out of court’
KLG Systel sells unit to arm
Thomson Corpn completes Reuters Group acquisition
3i Infotech raises Rs 500-cr debt to fund domestic buys
Siro Clinpharm buys German clinical research firm
PowerGrid full-year net profit rises 15.5%
Carlson launches its fourth resort in India
GMR Energy buys 5% stake in SA co
‘Public-private partnership needs to be long-term to succeed’
Dow Europe forms venture with Gujarat Alkalies
Saffron Group funds to pick up stake in Parsvnath’s Mumbai project
Burson-Marsteller forms South Asia network
SAIL, Steel Complex MoU to be signed next month
Religare into commercial vehicles financing


Smartbuy



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line